🇺🇸 FDA
Patent

US 12024509

Therapeutic compounds as inhibitors of the orexin-1 receptor

granted A61PA61P19/10A61P25/00

Quick answer

US patent 12024509 (Therapeutic compounds as inhibitors of the orexin-1 receptor) held by C4X Discovery Limited expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4X Discovery Limited
Grant date
Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P19/10, A61P25/00, A61P25/04, A61P25/06